The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
Fan, F, Bashari, M H, Morelli, E, Tonon, G, Malvestiti, S, Vallet, S, Jarahian, M, Seckinger, A, Hose, D, Bakiri, L, Sun, C, Hu, Y, Ball, C R, Glimm, H, Sattler, M, Goldschmidt, H, Wagner, E F, Tassone, P, Jaeger, D, Podar, K
Published in Leukemia (01.07.2017)
Published in Leukemia (01.07.2017)
Get full text
Journal Article
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
GUPTA, D, TREON, S. P, SCHLOSSMAN, R. L, RICHARDSON, P, RALPH, P, WU, L, PAYVANDI, F, MULLER, G, STIRLING, D. I, ANDERSON, K. C, SHIMA, Y, HIDESHIMA, T, PODAR, K, TAI, Y. T, LIN, B, LENTZSCH, S, DAVIES, F. E, CHAUHAN, D
Published in Leukemia (01.12.2001)
Published in Leukemia (01.12.2001)
Get full text
Conference Proceeding
Journal Article
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Chauhan, Dharminder, Catley, Laurence, Li, Guilan, Podar, Klaus, Hideshima, Teru, Velankar, Mugdha, Mitsiades, Constantine, Mitsiades, Nicolas, Yasui, Hiroshi, Letai, Anthony, Ovaa, Huib, Berkers, Celia, Nicholson, Benjamin, Chao, Ta-Hsiang, Neuteboom, Saskia T.C., Richardson, Paul, Palladino, Michael A., Anderson, Kenneth C.
Published in Cancer cell (01.11.2005)
Published in Cancer cell (01.11.2005)
Get full text
Journal Article
A novel Bcl-2/Bcl-XL/Bcl-W inhibitor ABT-737 as therapy in multiple myeloma
CHAUHAN, D, VELANKAR, M, ANDERSON, K. C, BRAHMANDAM, M, HIDESHIMA, T, PODAR, K, RICHARDSON, P, SCHLOSSMAN, R, GHOBRIAL, I, RAJE, N, MUNSHI, N
Published in Oncogene (05.04.2007)
Published in Oncogene (05.04.2007)
Get full text
Journal Article
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
Hideshima, Teru, Mitsiades, Constantine, Akiyama, Masaharu, Hayashi, Toshiaki, Chauhan, Dharminder, Richardson, Paul, Schlossman, Robert, Podar, Klaus, Munshi, Nikhil C., Mitsiades, Nicholas, Anderson, Kenneth C.
Published in Blood (15.02.2003)
Published in Blood (15.02.2003)
Get full text
Journal Article
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells
Bhanot, Haymanti, Reddy, Mamatha M, Nonami, Atsushi, Weisberg, Ellen L, Bonal, Dennis, Kirschmeier, Paul T, Salgia, Sabrina, Podar, Klaus, Galinsky, Ilene, Chowdary, Tirumala K, Neuberg, Donna, Tonon, Giovanni, Stone, Richard M, Asara, John, Griffin, James D, Sattler, Martin
Published in Leukemia (01.07.2015)
Published in Leukemia (01.07.2015)
Get full text
Journal Article
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application
Hayashi, Toshiaki, Hideshima, Teru, Akiyama, Masaharu, Podar, Klaus, Yasui, Hiroshi, Raje, Noopur, Kumar, Shaji, Chauhan, Dharminder, Treon, Steven P., Richardson, Paul, Anderson, Kenneth C.
Published in British journal of haematology (01.01.2005)
Published in British journal of haematology (01.01.2005)
Get full text
Journal Article
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis
PODAR, K, GOUILL, S. L, ANDERSON, K. C, ZHANG, J, OPFERMAN, J. T, ZORN, E, TAI, Y.-T, HIDESHIMA, T, AMIOT, M, CHAUHAN, D, HAROUSSEAU, J.-L
Published in Oncogene (31.01.2008)
Published in Oncogene (31.01.2008)
Get full text
Journal Article
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma
RAJE, N, HIDESHIMA, T, KIZILTEPE, T, PODAR, K, OKAWA, Y, IKEDA, H, CARRASCO, R, RICHARDSON, P. G, CHAUHAN, D, MUNSHI, N. C, SHARMA, S, PARIKH, H, MUKHERJEE, S, CHABNER, B, SCADDEN, D, ANDERSON, K. C, RAAB, M, VALLET, S, CHHETRI, S, CIRSTEA, D, POZZI, S, MITSIADES, C, ROONEY, M
Published in Leukemia (01.05.2009)
Published in Leukemia (01.05.2009)
Get full text
Journal Article
Immunomodulatory analogs of thalidomide inhibit growth of Hs sultan cells and angiogenesis in vivo
LENTZSCH, S, LEBLANC, R, POCLAR, K, DAVIES, F, LIN, B, HIDESHIMA, T, CATLEY, L, STIRLING, D. I, ANDERSON, K. C
Published in Leukemia (2003)
Published in Leukemia (2003)
Get full text
Journal Article
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Raje, Noopur, Kumar, Shaji, Hideshima, Teru, Ishitsuka, Kenji, Chauhan, Dharminder, Mitsiades, Constantine, Podar, Klaus, Le Gouill, Steven, Richardson, Paul, Munshi, Nikhil C., Stirling, David I., Antin, Joseph H., Anderson, Kenneth C.
Published in Blood (15.12.2004)
Published in Blood (15.12.2004)
Get full text
Journal Article
S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON‐ELIGIBLE PATIENTS WITH NDMM (AGMT‐MM02 TRIAL)
Ludwig, H., Melchardt, T., Sormann, S., Zojer, N., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Schreder, M., Ruckser, R., Bozic, B, Krauth, M.‐T., Petzer, A., Schmitt, C, Machherndl‐Spandl, S., Agis, H., Fillitz, M., Pönisch, W., Knop, S., Paiva, B., Greil, R.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Novel therapies targeting the myeloma cell and its bone marrow microenvironment
Hideshima, T, Chauhan, D, Podar, K, Schlossman, R L, Richardson, P, Anderson, K C
Published in Seminars in oncology (01.12.2001)
Published in Seminars in oncology (01.12.2001)
Get more information
Journal Article
P033 Mcl-1 confers protection of breast cancer cells exposed to hypoxia: therapeutic implications
Bashari, M.H, Fan, F, Arn, M, Vallet, S, Opferman, J, Cardone, M.H, Schneeweiss, A, Jäger, D, Podar, K
Published in Breast (Edinburgh) (01.03.2015)
Published in Breast (Edinburgh) (01.03.2015)
Get full text
Journal Article
Cytokines and signal transduction
Hideshima, Teru, Podar, Klaus, Chauhan, Dharminder, Anderson, Kenneth C.
Published in Best practice & research. Clinical haematology (01.01.2005)
Published in Best practice & research. Clinical haematology (01.01.2005)
Get full text
Journal Article
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance
Chauhan, Dharminder, Li, Guilan, Podar, Klaus, Hideshima, Teru, Shringarpure, Reshma, Catley, Laurence, Mitsiades, Constantine, Munshi, Nikhil, Tai, Yu Tzu, Suh, Nanjoo, Gribble, Gordon W., Honda, Tadashi, Schlossman, Robert, Richardson, Paul, Sporn, Michael B., Anderson, Kenneth C.
Published in Blood (15.04.2004)
Published in Blood (15.04.2004)
Get full text
Journal Article